ESPACOMP Medication Adherence Reporting Guideline (EMERGE)

Research output: Contribution to journalArticlepeer-review

Standard Standard

ESPACOMP Medication Adherence Reporting Guideline (EMERGE). / De Geest, S.; Zullig, Leah L. ; Dunbar-Jacob, Jacqueline et al.
In: Annals of Internal Medicine, Vol. 169, No. 1, 03.07.2018, p. 30-35.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

De Geest, S, Zullig, LL, Dunbar-Jacob, J, Helmy, R, Hughes, D, Wilson, I & Vrijens, B 2018, 'ESPACOMP Medication Adherence Reporting Guideline (EMERGE)', Annals of Internal Medicine, vol. 169, no. 1, pp. 30-35. https://doi.org/10.7326/M18-0543

APA

De Geest, S., Zullig, L. L., Dunbar-Jacob, J., Helmy, R., Hughes, D., Wilson, I., & Vrijens, B. (2018). ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine, 169(1), 30-35. https://doi.org/10.7326/M18-0543

CBE

De Geest S, Zullig LL, Dunbar-Jacob J, Helmy R, Hughes D, Wilson I, Vrijens B. 2018. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine. 169(1):30-35. https://doi.org/10.7326/M18-0543

MLA

De Geest, S. et al. "ESPACOMP Medication Adherence Reporting Guideline (EMERGE)". Annals of Internal Medicine. 2018, 169(1). 30-35. https://doi.org/10.7326/M18-0543

VancouverVancouver

De Geest S, Zullig LL, Dunbar-Jacob J, Helmy R, Hughes D, Wilson I et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Annals of Internal Medicine. 2018 Jul 3;169(1):30-35. Epub 2018 Jun 26. doi: 10.7326/M18-0543

Author

De Geest, S. ; Zullig, Leah L. ; Dunbar-Jacob, Jacqueline et al. / ESPACOMP Medication Adherence Reporting Guideline (EMERGE). In: Annals of Internal Medicine. 2018 ; Vol. 169, No. 1. pp. 30-35.

RIS

TY - JOUR

T1 - ESPACOMP Medication Adherence Reporting Guideline (EMERGE)

AU - De Geest, S.

AU - Zullig, Leah L.

AU - Dunbar-Jacob, Jacqueline

AU - Helmy, Remon

AU - Hughes, Dyfrig

AU - Wilson, Ira

AU - Vrijens, Bernard

N1 - Dr. Hughes is supported by the Medical Research Council North West Hub for Trials Methodology Research (MR/K025635/1)

PY - 2018/7/3

Y1 - 2018/7/3

N2 - Research on assessing or managing medication adherence applies approaches from observational, interventional, and implementation science that spans many disciplines and demands coherent conceptualization, valid methods, appropriate analyses, and complete and accurate reporting. To ensure such reporting, the European Society for Patient Adherence, COMpliance, and Persistence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE) recommends standard reporting approaches based on an accepted taxonomy. This guideline is derived from a literature review, a reactive Delphi study with 26 medication adherence experts from many countries and disciplines, and feedback from ESPACOMP members. It is designed to supplement existing guidelines for health research reporting and is structured around 4 minimum reporting criteria and 17 items reflecting best reporting practice. By enhancing and harmonizing research reporting, EMERGE aims to advance research and, ultimately, patient outcomes.

AB - Research on assessing or managing medication adherence applies approaches from observational, interventional, and implementation science that spans many disciplines and demands coherent conceptualization, valid methods, appropriate analyses, and complete and accurate reporting. To ensure such reporting, the European Society for Patient Adherence, COMpliance, and Persistence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE) recommends standard reporting approaches based on an accepted taxonomy. This guideline is derived from a literature review, a reactive Delphi study with 26 medication adherence experts from many countries and disciplines, and feedback from ESPACOMP members. It is designed to supplement existing guidelines for health research reporting and is structured around 4 minimum reporting criteria and 17 items reflecting best reporting practice. By enhancing and harmonizing research reporting, EMERGE aims to advance research and, ultimately, patient outcomes.

U2 - 10.7326/M18-0543

DO - 10.7326/M18-0543

M3 - Article

VL - 169

SP - 30

EP - 35

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 1

ER -